SCHEMBL1505746

SCHEMBL1505746

NC1C[C@H](N)C[C@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23087129 1.00
SCHEMBL62100 1.00
SCHEMBL4818499 1.00
SCHEMBL24632096 1.00
SCHEMBL126555 1.00
Bromide SCHEMBL3946214 0.94
Hydrochloric Acid SCHEMBL14759306 0.94
Bromide SCHEMBL29165637 0.94
Bromide SCHEMBL3946215 0.94
Hydrochloric Acid SCHEMBL15812361 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013038134-A1 SYNTHESIS AND ANTICANCER ACTIVITY OF RUTHENIUM (11) CIS-CIS-1,3,5- TRIAMINOCYCLOHEXANE COMPLEXES UNIVERSITY OF YORK (GB) 2013-03-21 WO claimed
EP-1978997-A1 TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS Apollo Life Sciences Limited (AU) 2008-10-15 EP claimed
US-20070243132-A1 Transdermal delivery of pharmaceutical agents APOLLO LIFE SCIENCES LIMITED (AU) 2007-10-18 US claimed
WO-2007070983-A1 TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS APOLLO LIFE SCIENCES LIMITED (AU) 2007-06-28 WO claimed
CN-109415344-B Metal complexes 默克专利有限公司 2022-06-03 CN disclosed
US-11298364-B2 Methods and products for preventing and/or treating microorganism infections comprising iron chelators and non-iron porphyrins THE UNIVERSITY OF ADELAIDE (AU) 2022-04-12 US disclosed
CN-110573155-A Method and product for reducing blocking 阿德莱德大学 2019-12-13 CN disclosed
US-20190309171-A1 MULTIMERIC PROTECTED FLUORESCENT REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2019-10-10 US disclosed
EP-3484868-A1 METAL COMPLEXES Merck Patent GmbH (DE) 2019-05-22 EP disclosed
US-20180338985-A1 METHODS AND PRODUCTS FOR PREVENTING AND/OR TREATING MICROORGANISM INFECTIONS COMPRISING IRON CHELATORS AND NON-IRON PORPHYRINS THE UNIVERSITY OF ADELAIDE (AU) 2018-11-29 US disclosed
US-20150083657-A1 MEMBRANE AND METHOD FOR MAKING THE SAME GENERAL ELETRIC COMPANY (US) 2015-03-26 US disclosed
EP-2723480-A1 MEMBRANE WITH A LAYER COMPRISING POLYOLS AND A METALORGANIC COMPOUND ON A POLYAMIDE LAYER AND ITS PREPARATION General Electric Company (US) 2014-04-30 EP disclosed
US-20050250857-A1 Gelling agents NANO FIBER MATRICES B.V. (NL) 2005-11-10 US disclosed
EP-1506168-A2 GELLING AGENTS Applied NanoSystems B.V. (NL) 2005-02-16 EP disclosed
WO-2003097587-A2 GELLING AGENTS APPLIED NANOSYSTEMS B.V. (NL) 2003-11-27 WO disclosed
EP-1364941-A1 Gelling agents Applied NanoSystems B.V. (NL) 2003-11-26 EP disclosed
US-6589966-B1 A family of hexadentate Fe(II) chelators having marked antiproliferative activity against tumor cells is disclosed. The cytotoxic metal chelators and complexes of the present invention are represented by the general formula below: WAKE FOREST UNIVERSITY HEALTH SCIENCES 2003-07-08 US disclosed
EP-1064264-A4 CYTOTOXIC METAL CHELATORS AND METHODS FOR MAKING AND USING SAME UNIV WAKE FOREST (US) 2002-06-26 EP disclosed
EP-1064264-A1 CYTOTOXIC METAL CHELATORS AND METHODS FOR MAKING AND USING SAME WAKE FOREST UNIVERSITY (US) 2001-01-03 EP disclosed
WO-1999047502-A1 CYTOTOXIC METAL CHELATORS AND METHODS FOR MAKING AND USING SAME WAKE FOREST UNIVERSITY (US) 1999-09-23 WO disclosed